Ventricular Assist Devices and Chronic Kidney Replacement Therapy: Technology and Outcomes.


Journal

Advances in chronic kidney disease
ISSN: 1548-5609
Titre abrégé: Adv Chronic Kidney Dis
Pays: United States
ID NLM: 101209214

Informations de publication

Date de publication:
01 2021
Historique:
received: 31 07 2020
revised: 12 11 2020
accepted: 04 01 2021
entrez: 14 8 2021
pubmed: 15 8 2021
medline: 26 10 2021
Statut: ppublish

Résumé

Heart failure and kidney failure are very common conditions, precipitating and exacerbating each other. Left ventricular assist devices (LVADs) represent a relatively new technology for treatment of advanced heart failure. Kidney dysfunction, if present, makes candidate selection for LVADs challenging and contributes to multiple complications while the patients are on an LVAD support. Although kidney function generally improves after LVAD implantation, some patients develop acute and then chronic kidney disease sometimes requiring kidney replacement therapies (KRTs). Overall, chronic KRT in LVAD recipients is feasible and well tolerated, but routine technique of blood pressure monitoring should be adjusted to the continuous blood flow. Both hemodialysis and peritoneal dialysis can be used. Unique challenges for chronic KRT posed by the presence of LVAD are discussed in this review.

Identifiants

pubmed: 34389136
pii: S1548-5595(21)00002-1
doi: 10.1053/j.ackd.2021.01.002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-46

Informations de copyright

Copyright © 2021 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Omar Jawaid (O)

Krannert Institute of Cardiology, Indiana University, Indianapolis, IN.

Anna Gaddy (A)

Division of Nephrology, Indiana University, Indianapolis, IN.

Hesham R Omar (HR)

Online Care Group (AmericanWell.com), Chicago, IL Online Care Group (AmericanWell.com), Chicago, IL.

Maya Guglin (M)

Krannert Institute of Cardiology, Indiana University, Indianapolis, IN. Electronic address: mguglin@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH